Waters Corp. Stock
Waters Corp. Stock
The Waters Corp. price is unchanged compared to yesterday.
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Waters Corp. stock is not clear.
Pros and Cons of Waters Corp. in the next few years
Pros
?
Growth compared to competition
?
Brand
?
Market Position
Cons
?
Conscious of the environment
?
Shareholder structure
?
Worthwhile Investment for the next years
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Waters Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Waters Corp. | 0.000% | 5.797% | 14.063% | 73.810% | 44.554% | 64.045% | 145.833% |
| Cerner Corp. | 0.150% | -0.480% | 5.338% | 7.039% | 3.513% | 26.190% | 38.457% |
| Veeva Systems A | 1.790% | 5.773% | 25.735% | 25.951% | 13.772% | 259.294% | 747.374% |
| Varian Medical Systems Inc. | -0.130% | 0.000% | -0.201% | 40.189% | 3.916% | 40.626% | 178.852% |
Other discussions about Waters Corp. Stock
New thread ForumNews
Waters Arc Premier System Delivers Increased Precision and Certainty in Chromatographic Results
Waters Corporation (NYSE:WAT) today introduced the Waters™ Arc™ Premier System, the first liquid chromatography system optimized for chromatographic separations on 2.5 – 3.5 micron columns to also
Waters Sets New Standard in High Resolution Mass Spectrometry with SELECT SERIES Multi Reflecting Time-of-Flight Platform
Waters Corporation (NYSE:WAT) today introduced the Waters™ SELECT SERIES™ MRT, a high-resolution mass spectrometer that combines Multi Reflecting Time-of-Flight (MRT) technology with both enhanced
Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) to Advance Clinical Research of Infectious Diseases
Waters Corporation (NYSE:WAT) today introduced a new RUO LC-MS test method to advance critical infectious disease research. Waters™ SARS-CoV-2 LC-MS Kit (RUO) uses an orthogonal analytical method